Immunostaining with anti‐GzmB demonstrated that circFat1 KD plus anti‐PD1 also recruited more GzmB+ CD8+ T cells into tumor tissues compared with anti‐PD1 or circFat1 KD alone (Figure S7B,C, Supporting Information). This evidence concerns the gene CD8A and neoplasm.